A Study to Evaluate Combination Therapy of Oncolytic Vaccinia Virus (hV01) and PD-1 Inhibitor in Advanced Solid Tumors.
Clinical trial NCT07185243 · RECRUITING
Trial details
- NCT number
- NCT07185243
- Sponsor
- Hangzhou Converd Co., Ltd.
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-23
- Primary completion
- 2027-06-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.